{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:24:28Z","timestamp":1786998268042,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jsesreviewsreportstech.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JSES Reviews, Reports, and Techniques"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xrrt.2025.100613","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:28:34Z","timestamp":1761949714000},"page":"100613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["How do GLP-1 receptor agonists influence the progression of shoulder pathology? A matched cohort analysis"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9690-6889","authenticated-orcid":false,"given":"William R.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5295-7662","authenticated-orcid":false,"given":"Nicholas C.","family":"Bank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6071-8944","authenticated-orcid":false,"given":"Bradley J.","family":"Lauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Creighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Justin","family":"Mistovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xrrt.2025.100613_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3892\/ijmm.2014.1787","article-title":"Expression of glucagon-like peptide-1 receptor and glucose-dependent insulinotropic polypeptide receptor is regulated by the glucose concentration in mouse osteoblastic MC3T3-E1 cells","volume":"34","author":"Aoyama","year":"2014","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.xrrt.2025.100613_bib2","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.1016\/j.jse.2024.11.041","article-title":"GLP-1 agonist use increases the incidence of adhesive capsulitis and odds of requiring operative management in type 2 diabetes patients: a matched propensity score analysis","volume":"34","author":"Bergstein","year":"2025","journal-title":"J Shoulder Elbow Surg"},{"key":"10.1016\/j.xrrt.2025.100613_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41419-017-0217-y","article-title":"Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.xrrt.2025.100613_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/j.sart.2024.10.001","article-title":"The impact of GLP-1 receptor agonists on postoperative outcomes following total shoulder arthroplasty","volume":"35","author":"Choudhury","year":"2025","journal-title":"Semin Arthroplasty"},{"key":"10.1016\/j.xrrt.2025.100613_bib5","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"10.1016\/j.xrrt.2025.100613_bib6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jse.2024.07.045","article-title":"Does use of glucagon-like peptide-1 agonists increase perioperative complications in patients undergoing shoulder arthroplasty?","volume":"34","author":"Elsabbagh","year":"2025","journal-title":"J Shoulder Elbow Surg"},{"key":"10.1016\/j.xrrt.2025.100613_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038444","article-title":"Favorable liver and skeletal muscle changes in patients with MASLD and T2DM receiving glucagon-like peptide-1 receptor agonist: a prospective cohort study","volume":"103","author":"Kakegawa","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.xrrt.2025.100613_bib8","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.arth.2024.06.008","article-title":"The five-year incidence of progression to osteoarthritis and total joint arthroplasty in patients prescribed glucagon-like peptide 1 receptor agonists","volume":"39","author":"Lavu","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.xrrt.2025.100613_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3094642","article-title":"Anti-Inflammatory effects of GLP-1-Based therapies beyond glucose control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.xrrt.2025.100613_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.108968","article-title":"The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type \u2161 collagen and aggrecan in human SW1353 chondrocytes","volume":"322","author":"Li","year":"2020","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.xrrt.2025.100613_bib11","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Web site and R package for computing E-values","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"key":"10.1016\/j.xrrt.2025.100613_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.sart.2025.05.006","article-title":"Glucagon-Like Peptide-1 receptor agonist use is not associated with reduced postoperative complications in Obese patients after total shoulder arthroplasty","volume":"35","author":"Megerian","year":"2025","journal-title":"Semin Arthroplasty"},{"key":"10.1016\/j.xrrt.2025.100613_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.xrrt.2025.100613_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jot.2022.02.001","article-title":"Targeting the GLP-1\/GLP-1R axis to treat osteoarthritis: a new opportunity?","volume":"32","author":"Meurot","year":"2022","journal-title":"J Orthop Translat"},{"key":"10.1016\/j.xrrt.2025.100613_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jcp.22243","article-title":"Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor","volume":"225","author":"Nuche-Berenguer","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.xrrt.2025.100613_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bone.2015.08.006","article-title":"Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice","volume":"81","author":"Pereira","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.xrrt.2025.100613_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/23259671241297157","article-title":"The impact of contemporary glucagon-like Peptide-1 receptor agonists on the onset, severity, and conversion to arthroplasty in hip and knee osteoarthritis","volume":"13","author":"Porto","year":"2025","journal-title":"Orthop J Sports Med"},{"key":"10.1016\/j.xrrt.2025.100613_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12950-019-0218-y","article-title":"The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA\/CREB pathway in a rat model of knee osteoarthritis","volume":"16","author":"Que","year":"2019","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.xrrt.2025.100613_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/ph18030399","article-title":"Semaglutide as a GLP-1 agonist: a breakthrough in obesity treatment","volume":"18","author":"Salvador","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.xrrt.2025.100613_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.arthro.2024.09.057","article-title":"Lower risk of postoperative complications and Rotator Cuff Retear associated with semaglutide use in patients with type II diabetes mellitus undergoing arthroscopic Rotator Cuff Repair","volume":"41","author":"Seddio","year":"2025","journal-title":"Arthroscopy"},{"key":"10.1016\/j.xrrt.2025.100613_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2024.100330","article-title":"Understanding the impact of diabetes on bone health: a clinical review","volume":"24","author":"Sharma","year":"2024","journal-title":"Metabol Open"},{"key":"10.1016\/j.xrrt.2025.100613_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.xrrt.2025.100613_bib23","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s00198-018-4649-8","article-title":"Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials","volume":"29","author":"Zhang","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.xrrt.2025.100613_bib24","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard-2023-223845","article-title":"Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort","volume":"82","author":"Zhu","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["JSES Reviews, Reports, and Techniques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666639125002287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666639125002287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:42:31Z","timestamp":1768524151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666639125002287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666639125002287"],"URL":"https:\/\/doi.org\/10.1016\/j.xrrt.2025.100613","relation":{},"ISSN":["2666-6391"],"issn-type":[{"value":"2666-6391","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How do GLP-1 receptor agonists influence the progression of shoulder pathology? A matched cohort analysis","name":"articletitle","label":"Article Title"},{"value":"JSES Reviews, Reports, and Techniques","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xrrt.2025.100613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Shoulder and Elbow Surgeons.","name":"copyright","label":"Copyright"}],"article-number":"100613"}}